Suppliers / Zhejiang Wild Wind Pharmaceutical Co.,Ltd
Zhejiang Wild Wind Pharmaceutical Co.,Ltd
China Updated 9 July 2026
Zhejiang Wild Wind Pharmaceutical Co.,Ltd is an API manufacturer based in China. It holds 4 active US drug master files across a filed portfolio of 4 molecules. Its GMP standing is certified by MFDS (Korea) and EMA.
2
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Sources: FDA Establishment Registration, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.
Registered plants
| Site | FDA FEI |
| Dongyang, China | Not on file |
| China, China | 3006230668 |
What they file, and where
| Molecule | Regulators | Docs |
| Levodopa | SFDA (Saudi Arabia), US FDA | 2 |
| Carbidopa | US FDA | 1 |
| Caspofungin | US FDA | 1 |
| Methyldopa | US FDA | 1 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| MFDS (Korea) | None | 2 |
| EMA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Zhejiang Wild Wind Pharmaceutical Co.,Ltd comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates